Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for ERK 1
Most Correlated Studies
- ERK oscillation-dependent gene expression patterns
- Mouse chondrocytes treated with inhibitors of PI3K, histone deacetylase, and Mek/ERK pathway
- MDCK cells treated with hepatocyte growth factor and MAPK ERK pathway inhibitors
- Embryonic stem cells gene expression upon prolonged inhibition of GSK3 and ERK
- Melanoma A375P cell line treated with ERK dimerization inhibitor, either DEL22379 or SCH772984
Most Relevant Literature
- MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
- Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target muta…
- Resveratrol Is a Natural Inhibitor of Human Intestinal Mast Cell Activation and Phosphorylation of M…
- Prolonged arsenic exposure increases tau phosphorylation in differentiated SH-SY5Y cells: The contri…
- The fibrillin-1 RGD motif posttranscriptionally regulates ERK1/2 signaling and fibroblast proliferat…
Most Relevant Clinical Trials
- ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
- Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ER…
- Targeted PARP or MEK/ERK Inhibition in Patients With Pancreatic Cancer
- Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma
- Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibr…
